51.5K
views
118
authors
14
articles
Editors
3
Impact
Loading...
Systematic Review
25 November 2021

Background: Heart failure with improved ejection fraction (HFimpEF) is classified as a new type of heart failure, and its prevalence and prognosis are not consistent in previous studies. There is no systematic review and meta-analysis regarding the prevalence and prognosis of the HFimpEF.

Method: A systematic search was performed in MEDLINE, EMBASE, and Cochrane Library from inception to May 22, 2021 (PROSPERO registration: CRD42021260422). Studies were included for analysis if the prognosis of mortality or hospitalization were reported in HFimpEF or in patients with heart failure with recovered ejection fraction (HFrecEF). The primary outcome was all-cause mortality. Cardiac hospitalization, all-cause hospitalization, and composite events of mortality and hospitalization were considered as secondary outcomes.

Result: Nine studies consisting of 9,491 heart failure patients were eventually included. During an average follow-up of 3.8 years, the pooled prevalence of HFimpEF was 22.64%. HFimpEF had a lower risk of mortality compared with heart failure patients with reduced ejection fraction (HFrEF) (adjusted HR: 0.44, 95% CI: 0.33–0.60). HFimpEF was also associated with a lower risk of cardiac hospitalization (HR: 0.40, 95% CI: 0.20–0.82) and the composite endpoint of mortality and hospitalization (HR: 0.56, 95% CI: 0.44–0.73). Compared with patients with preserved ejection fraction (HFpEF), HFimpEF was associated with a moderately lower risk of mortality (HR: 0.42, 95% CI: 0.32–0.55) and hospitalization (HR: 0.73, 95% CI: 0.58–0.92).

Conclusion: Around 22.64% of patients with HFrEF would be treated to become HFimpEF, who would then obtain a 56% decrease in mortality risk. Meanwhile, HFimpEF is associated with lower heart failure hospitalization. Further studies are required to explore how to promote left ventricular ejection fraction improvement and improve the prognosis of persistent HFrEF in patients.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021260422, identifier: CRD42021260422.

9,070 views
44 citations
Recommended Research Topics
Frontiers Logo

Frontiers in Cardiovascular Medicine

Epigenetics in Heart Failure Developing: The orchestra of etiology and comorbidities
Edited by Alexander E Berezin, Ioana Mozos, Daniel Petrovič
33.9K
views
23
authors
6
articles
Frontiers Logo

Frontiers in Cardiovascular Medicine

Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
Edited by Alexander E Berezin, Borut Peterlin, Michael Lichtenauer, Ioana Mozos
48.2K
views
27
authors
5
articles
Frontiers Logo

Frontiers in Cardiovascular Medicine

Machine Learning and Data Science in Heart Failure and Stroke
Edited by Leonardo Roever MHS, PhD, Post-Doctorate, MBA (Data Science ), Qingpeng Zhang
37.3K
views
82
authors
11
articles
Frontiers Logo

Frontiers in Cardiovascular Medicine

Molecular and Cellular Mechanisms of Heart Failure: Pathophysiology, pathogenesis and therapeutics
Edited by Amy Li, Kenneth Scott Campbell, Sean Lal
44.5K
views
85
authors
14
articles
Frontiers Logo

Frontiers in Cardiovascular Medicine

Contemporary Applications of Machine Learning and Artificial Intelligence for the Management of Heart Failure
Edited by Andre Rodrigues Duraes, Mansueto Gomes-Neto, Edimar Alcides Bocchi
10K
views
29
authors
5
articles